Cycling Deep Brain Stimulation on Parkinson's Disease Gait
- Conditions
- Parkinson Disease
- Interventions
- Other: Cycling deep brain stimulation
- Registration Number
- NCT04408573
- Lead Sponsor
- University of Sao Paulo General Hospital
- Brief Summary
Our hypothesis is that cycling DBS stimulation would be superior or non-inferior to regular DBS stimulation in Parkinson's disease patients with gait impairment. The objective of this study is compare gait disorders in patients with Parkinson's disease and DBS in 4 different scenarios: 1) regular continuous high frequency (\>130Hz) stimulation, 2) cycling high frequency (\>130Hz) stimulation (40sec on, 2sec off), 3) low-frequency (80Hz) continuous stimulation and 4) cycling low frequency (80Hz) stimulation (40sec on, 2sec off)
- Detailed Description
Gait disorders such as falls, freezing of gait, reduction of speed, shuffling, and multi-stepped turning are common in patients with moderate and advanced Parkinson's disease. Compared to appendicular symptoms (bradykinesia, tremor, and rigidity), gait disorders tend to be more resistant to medical and regular deep brain stimulation treatment, and greatly impairs patients' quality of life and daily living activities. Some stimulation strategies have been tried to improve gait in Parkinson's disease patients, but so far most of them resulted in concomitant worsening of appendicular symptoms. However, new stimulation strategies such as cycling stimulation can potentially improve gait disorders without impairment of appendicular symptoms.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- Diagnosis of idiopathic Parkinson's disease
- Currently receiving Deep Brain Stimulation as a Parkinson's disease treatment
- Hoehn & Yahr stage between 2-4 during off-medication
- Underlying gait disorders despite optimal medical and stimulation treatment: score over or equal to 1 in the subitem 2.12 of the MDS-UPDRS scale
- Willingness to comply with all study procedures
- Active moderate/severe psychiatric condition
- Active infection or other uncontrolled moderate/grave comorbidities
- Treatment with experimental drug
- Pregnancy or breast-feeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Continuous Low Frequency Cycling deep brain stimulation Patient is stimulated with the same polarity and pulse width as the currently chosen stimulation protocol, but with low frequency (80Hz). Voltage/current will be adjusted to maintain TEED similar to that on the regular stimulation protocol. Cycling Low Frequency Cycling deep brain stimulation Patient is stimulated with the same polarity and pulse width as the currently chosen stimulation protocol, but with low frequency (80Hz) and cycling stimulation: 40sec On - 02 sec OFF. Voltage/current will be adjusted to maintain TEED similar to that on the regular stimulation protocol. Cycling High Frequency Cycling deep brain stimulation Patient is stimulated with the same polarity, voltage/current, pulse width and frequency as the currently chosen stimulation protocol, but with cycling stimulation: 40sec On - 02 sec OFF
- Primary Outcome Measures
Name Time Method Change in the New Freezing of Gait Questionnaire Baseline + after 2 weeks + after 4 weeks + after 6 weeks The New Freezing of Gait Questionnaire (NFOG-Q) is a self-reportable questionnaire consisting of 9 items that measure freezing of gait (FOG). Scores vary from 0 - 28. Higher scores mean a worse outcome.
Change in the part II of the Unified Parkinson's disease rating scale Baseline + after 2 weeks + after 4 weeks + after 6 weeks The part II of the Unified Parkinson's disease rating scale (UPDRS II) is a self-reportable questionnaire consisting of 13 items that measure functionality (motor experiences of daily living). Scores vary from 0 - 52. Higher scores mean a worse outcome.
- Secondary Outcome Measures
Name Time Method Number of falls Baseline + after 2 weeks + after 4 weeks + after 6 weeks Patients will be questioned about number of times they experienced falls in the last 2 weeks. Higher numbers mean a worse outcome.
Change in The Parkinson's Disease Questionnaire (PDQ-39) Baseline + after 2 weeks + after 4 weeks + after 6 weeks This questionnaire assesses how often people affected by Parkinson's experience difficulties across 8 dimensions of daily living. The 39 item questionnaire offers a patient reported measure of health status and quality of life and is the most frequently used disease-specific health status measure.Scores vary from 0 - 156. Higher scores mean a worse outcome.
Change in Activities-Specific Balance Confidence Scale (ABC scale) Baseline + after 2 weeks + after 4 weeks + after 6 weeks The ABC scale is a self-report measure of balance in performing various activities without losing balance or experiencing a sense of unsteadiness. Scores vary from 0 - 100. Higher scores mean a better outcome.
Change in Falls Efficacy Scale Baseline + after 2 weeks + after 4 weeks + after 6 weeks The Falls Efficacy Scale (FES) is a sixteen-item test rated on a 10-point scale from not confident at all to completely confident. It is correlated with difficulty getting up from a fall and level of anxiety. Scores vary from 16 - 64. Higher scores mean a worse outcome.
Trial Locations
- Locations (1)
Hospital das Clínicas da Faculdade de Medicina da USP
🇧🇷São Paulo, SP, Brazil